What is the price target for JUNS stock?
7 analysts have analysed JUNS and the average price target is 25.5 USD. This implies a price increase of 5894.36% is expected in the next year compared to the current price of 0.4254.
NASDAQ:JUNS • US48208B2034
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for JUPITER NEUROSCIENCES INC (JUNS).
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 21.8K | 12.375M 56,666.06% | 7.505M -39.35% | ||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -3.871M -12.77% | -3.09M 20.17% | -8.909M -188.31% | 2.694M 130.24% | -10.651M -495.35% | |
| Operating Margin | N/A | N/A | -40,865.60% | 21.77% | -141.92% | |
| EPS YoY % growth | N/A | N/A | -0.26 -403.92% | 0.06 123.81% | -0.27 -533.33% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.05 -2.00% | -0.05 27.14% | -0.05 27.14% | 0.19 389.25% | -0.05 | -0.07 -40.00% | -0.07 -40.00% | -0.07 -136.84% |
| Revenue Q2Q % growth | 229.5K | 408K | 614.04K | 11.123M 50,459.09% | 1.196M 421.13% | 1.559M 282.11% | 2.045M 233.04% | 2.705M -75.68% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -1.92M -24.81% | -1.874M 17.27% | -1.815M 21.01% | 8.302M 395.57% | -2.21M -15.14% | -2.828M -50.95% | -2.915M -60.65% | -2.697M -132.48% |
All data in USD
7 analysts have analysed JUNS and the average price target is 25.5 USD. This implies a price increase of 5894.36% is expected in the next year compared to the current price of 0.4254.
The consensus EPS estimate for the next earnings of JUPITER NEUROSCIENCES INC (JUNS) is -0.05 USD and the consensus revenue estimate is 229.50K USD.
The consensus rating for JUPITER NEUROSCIENCES INC (JUNS) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.